Pibrentasvir

Molecular mass: 1,113.201 g/mol  PubChem compound: 58031952

Active ingredient description

Pibrentasvir is a pan-genotypic inhibitor of HCV nonstructural protein 5A (NS5A), which is essential for viral RNA replication and virion assembly.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J05AP Antivirals for treatment of HCV infections J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals
Discover more medicines within J05AP

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 1353900-92-1
DrugBank Drug: DB13878
PubChem Compound: 58031952
RxNorm Ingredient: 1940636
SNOMED-CT Concept: 736836002
Pibrentasvir (substance)
UNII Identifier: 2WU922TK3L
PIBRENTASVIR

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.